Medicines
- Adstiladrin nadofaragene firadenovec-vncg · No generic yet Non-muscle-invasive bladder cancer not helped by BCG
- Balversa erdafitinib · No generic yet Advanced urothelial (bladder) cancer with an FGFR3 change
- Bavencio avelumab · No generic yet Advanced urothelial (bladder) cancer
- Doxorubicin No generic yet Stomach, bladder and thyroid cancer
- Imfinzi durvalumab · No generic yet Bladder cancer
- Inlexzo gemcitabine intravesical · No generic yet Bladder cancer not helped by BCG treatment
- Jelmyto mitomycin · No generic yet Upper urinary tract cancer (low-grade UTUC)
- Keytruda pembrolizumab · No generic yet Bladder and kidney cancers
- Keytruda Qlex pembrolizumab and berahyaluronidase alfa-pmph · No generic yet Bladder and kidney cancers
- Opdivo nivolumab · No generic yet Bladder and urinary tract cancer (urothelial carcinoma)
- Opdivo Qvantig nivolumab and hyaluronidase-nvhy · No generic yet Bladder and urinary tract cancer (urothelial carcinoma)
- Padcev Ejfv enfortumab vedotin · No generic yet Advanced urothelial cancer (bladder and urinary tract cancer); Bladder cancer that has grown into the bladder muscle
- Tecentriq atezolizumab · No generic yet Bladder cancer that has grown into the muscle
- Tecentriq Hybreza atezolizumab and hyaluronidase-tqjs · No generic yet Bladder cancer that has grown into the muscle
- Zusduri mitomycin · No generic yet Recurring low-grade bladder cancer (not muscle-invasive)
From each medicine’s FDA label. Only your prescriber can say which one is right for you, and many are prescribed for other reasons too.